In the BioHarmony Drug Report Database

"Preview" Icon

Methylergonovine

Methergine (methylergonovine) is a small molecule pharmaceutical. Methylergonovine was first approved as Methergine on 1982-01-01. It is used to treat postpartum hemorrhage in the USA. It is known to target 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 2C, 5-hydroxytryptamine receptor 1F, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, and Soluble cytochrome b562.

 

Trade Name

 

Methergine
 

Common Name

 

methylergonovine
 

ChEMBL ID

 

CHEMBL1201356
 

Indication

 

postpartum hemorrhage
 

Drug Class

 

Ergot alkaloid derivatives; vinca alkaloids

Image (chem structure or protein)

Methylergonovine structure rendering